FDA Inspection 872367 — Fareva Amboise

Fareva Amboise — FEI 3000234005

The FDA completed an inspection of Fareva Amboise on March 18, 2014 in Poce Sur Cisse. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 9 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 18, 2014
Fiscal Year
2014
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Poce Sur Cisse (France)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
145121 CFR 211.113(b)Procedures for sterile drug products
189121 CFR 211.165(f)Failing drug products not rejected
202821 CFR 211.192Extent of discrepancy, failure investigations
430321 CFR 211.67(b)Written procedures fail to include
432021 CFR 211.84(d)(6)Microbiological Contamination Exam
432521 CFR 211.110(a)Control procedures fail to include the following
438021 CFR 211.198(b)(3)Determination not to conduct investigation of complaint
440021 CFR 211.186(b)(8)Description of containers, labels, et. al.